A Study of LY3039478 in Participants With Advanced Cancer

NCT01695005 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

247

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms
Neoplasm Metastasis
Lymphoma

Interventions

DRUG: LY3039478
DRUG: Prednisone

Sponsor

Eli Lilly and Company